You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

epirubicin

Showing 26 - 50 of 173
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Marginal Zone Lymphoma Trial in Zhengzhou (Bortezomib, Rituximab, Epirubicin)

Recruiting
  • Marginal Zone Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Aug 15, 2021

Peripheral T-cell Lymphoma Targeted Therapy Trial in Tianjin (Azacitidine, Chidamide, Cyclophosphamide)

Enrolling by invitation
  • Peripheral T-cell Lymphoma Targeted Therapy
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Insititute & Hospital
Jan 9, 2023

Breast Cancer Trial in Sweden (Trastuzumab deruxtecan, Docetaxel, Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan
  • +9 more
  • Malmö, Sweden
  • +6 more
Jun 8, 2023

Breast Cancer Trial in Beijing (Pembrolizumab, Paclitaxel, Epirubicin)

Recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Dec 28, 2022

Diffuse Large B Cell Lymphoma, CD79A Gene Mutation, CD79B Gene Mutation Trial in Zhengzhou (Rituximab, Zanubrutinib,

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jan 22, 2022

Diffuse Large B Cell Lymphoma Trial in Zhengzhou (Rituximab, Lenalidomide, Cyclophosphamide)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Aug 15, 2021

Triple Negative Breast Cancer Trial in Chengdu (Camrelizumab, Apatinib, Nab-paclitaxel)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Jul 6, 2022

Breast Cancer Trial in Beijing (doxorubicin, epirubicin, pirarubicin)

Not yet recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital, ChineseAMS
Mar 17, 2022

Breast Cancer Trial in Budapest (Tamoxifen, Goserelin, Letrozole 2.5Mg Tab)

Not yet recruiting
  • Breast Cancer
  • Budapest, Hungary
    National Institute of Oncolgy
Nov 20, 2021

Malignant Tumor of Breast Trial in Germany (Pembrolizumab, nab-paclitaxel, Epirubicin)

Completed
  • Malignant Neoplasm of Breast
  • Tübingen, Baden-Württemberg, Germany
  • +3 more
Apr 3, 2021

Triple Negative Breast Cancer Trial in Ile-Ife, Ibadan, Lagos (Epirubicin, Cyclophosphamide, Paclitaxel)

Recruiting
  • Triple Negative Breast Cancer
  • Epirubicin
  • +3 more
  • Ile-Ife, Oshun, Nigeria
  • +3 more
Feb 16, 2022

Breast Tumor, Breast Cancer, Breast Tumors Trial in Shanghai (Dalpiciclib, Pyrotinib, SHR-A1811)

Not yet recruiting
  • Breast Neoplasm
  • +9 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center Shanghai, China, 200032
Oct 13, 2022

Breast Cancer, Triple Negative Breast Cancer, Luminal B Trial in Belgium (Paclitaxel, Epirubicin, Cyclophosphamide)

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Charleroi, Hainaut, Belgium
  • +3 more
Aug 2, 2022

Neoadjuvant Operable Breast Cancer Trial in Paris, Villejuif (Fluorouracile, Epirubicin, Cyclophosphamide)

Completed
  • Neoadjuvant Operable Breast Cancer
  • Paris, France
  • +1 more
Mar 14, 2022

Breast Cancer Trial in Guangzhou (Everolimus, Letrozole, Fluorouracil)

Completed
  • Breast Cancer
  • Guangzhou, Guangdong, China
    Sun-Yat-Sen Memorial Hospital of Sun-Yat-Sen University
Sep 22, 2021

Gastric Cancer Trial in ShangHai (Epirubicin, Oxaliplatin, Capecitabine)

Completed
  • Gastric Cancer
  • Epirubicin
  • +2 more
  • ShangHai, Shanghai, China
    Fudan University Cancer Hospital
Oct 18, 2021

Classical Hodgkin Lymphoma Trial in Zhengzhou (Camrelizumab, Epirubicin, Vincristine)

Recruiting
  • Classical Hodgkin Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Dec 29, 2020

Triple Negative Breast Cancer Trial in Guangzhou (Sintilimab, Anlotinib, Nab paclitaxel)

Recruiting
  • Triple Negative Breast Cancer
  • Guangzhou, Guangdong, China
    NeoSACT
Oct 9, 2021

Breast Cancer Trial in Houston (Paclitaxel, Eribulin, 5-Fluorouracil)

Completed
Has Results
  • Breast Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 26, 2021

Down Syndrome, Acute Lymphoblastic Leukemia, Childhood Cancer Trial in Worldwide (Daunorubicin, Prednisolone, Vincristine)

Recruiting
  • Down Syndrome
  • +2 more
  • Shatin, New Territories, Hong Kong
  • +9 more
Sep 26, 2022

Inflammatory Breast Cancer Trial (Docetaxel, Cyclophosphamide, Epirubicin)

Completed
  • Inflammatory Breast Cancer
  • (no location specified)
Feb 17, 2021

Breast Tumors Trial in Mönchengladbach (drug, diagnostic test, procedure)

Active, not recruiting
  • Breast Neoplasms
  • Perjeta Injectable Product
  • +13 more
  • Mönchengladbach, Germany
    Evangelisches Krankenhaus Bethesda Mönchengladbach
Oct 4, 2022

Breast Cancer Trial in Canada, United States (Epirubicin, Cyclophosphamide, Docetaxel)

Completed
Has Results
  • Breast Cancer
  • Epirubicin
  • +4 more
  • Huntsville, Alabama
  • +35 more
Oct 4, 2021

Breast Cancer Trial in Nanjing (Pyrotinib, Trastuzumab, Pertuzumab)

Recruiting
  • Breast Cancer
  • Nanjing, Jiangsu, China
    the First Affiliated Hospital of Nanjing Medical University
Jun 2, 2021

Early-stage Breast Cancer, HER2-positive Breast Cancer Trial in Sweden (Docetaxel, Carboplatin, Trastuzumab)

Terminated
  • Early-stage Breast Cancer
  • HER2-positive Breast Cancer
  • Göteborg, Sweden
  • +7 more
Sep 22, 2021